as on October 28, 2025 at 4:01 pm IST
Day's Low
Day's High
0.90%
Downside
1.57%
Upside
52 Week's Low
52 Week's High
10.08%
Downside
52.35%
Upside
as on October 28, 2025 at 4:01 pm IST
Market Cap
₹27,002.35 Cr
Return on Equity (ROE)
9.76
PE Ratio (TTM)
274.51
Return on capital employed (ROCE)
12.31
Industry PE ratio
41.98
Beta (LTM)
1.08
P/B Ratio
3.99
Dividend Yield
0.06
PEG Ratio
527.91
Quarterly Earnings Growth YOY
-7.83
EPS (TTM)
0.69
Sector
Pharmaceuticals
Book Value
61.35
Technical Analysis
Bullish
View Technical Analysis
as on October 28, 2025 at 4:01 pm IST
Piramal Pharma in the last 5 years
Lowest (-516.41x)
January 5, 2024
Industry (41.98x)
October 27, 2025
Today (274.51x)
October 27, 2025
Highest (2011.42x)
June 25, 2024
Today’s Price to Earnings Ratio: 274.51x
Compare market cap, revenue, PE, and other key metrics of Piramal Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 27,002.35 | 1.38% | 0.69 | 91 | 9,151 | |
| BUY | 32,535.42 | 29.7% | 0.68 | 264 | 1,197 | |
| BUY | 17,908.51 | 14.42% | 0.71 | 836 | 7,234 | |
| NA | 4,324.57 | -4.05% | 1.88 | -343 | 71 | |
| BUY | 13,811.03 | 40.41% | 0.67 | 244 | 1,515 |
Based on 9 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 9 analysts, 100% of analysts recommend a 'BUY' rating for Piramal Pharma. Average target price of ₹260.89
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Piramal Pharma.
What analysts predicted
28.43%UPSIDE
Target Price
₹260.89
Current Price
₹202.1
Analyzed by
9 Analysts
High
₹325
Target
₹260.89
Low
₹230
Piramal Pharma target price ₹260.89, a slight upside of 28.43% compared to current price of ₹202.1. According to 9 analysts rating.
Source: S&P Global Market Intelligence
Investment in Piramal Pharma Ltd Shares on INDmoney has dropped by -21.04% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Piramal Pharma Ltd Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:15% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Piramal Pharma.
Piramal Pharma Ltd’s net profit jumped 7.83% since last year same period to ₹-81.70Cr in the Q1 2025-2026. On a quarterly growth basis, Piramal Pharma Ltd has generated -153.22% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Piramal Pharma Ltd has declared dividend of ₹0.14 per share on 14 May 2025 - translating a dividend yield of 0.07%.
Read More about DividendsCheck stock indices that include Piramal Pharma.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, PPLPHARMA stock has moved up by 3.0%
MF Holding Up
![]()
Mutual Funds have increased holdings from 12.32% to 13.11% in Sep 2025 quarter
Retail Holding Up
![]()
Retail Investor have increased holdings from 19.45% to 19.47% in Sep 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 34.86% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Divis Laboratories Ltd has given 11.6% return, outperforming this stock by 29.2%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 124.6% return, outperforming this stock by 96.4%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 153.5 Cr → -81.7 Cr (in ₹), with an average decrease of 153.2% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 2.81K Cr → 2.03K Cr (in ₹), with an average decrease of 27.8% per quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 12.91% to 12.32% in Sep 2025 quarter
View the latest movement in Piramal Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.
Piramal Pharma Options
Piramal Pharma Futures
| Organisation | Piramal Pharma Ltd |
| Industry | Pharmaceuticals |
| CEO | Nandini Piramal |
| E-voting on shares | Click here to vote |
Piramal Pharma share price today stands at ₹202.1 as on at the close of the market. Piramal Pharma share today touched a day high of ₹205.28 and a low of ₹200.28.
Piramal Pharma touched a 52 week high of ₹307.9 and a 52 week low of ₹181.73. Piramal Pharma share price today i.e. is closed at ₹202.1, which is -34.36% down from its 52 week high and 11.21% up from its 52 week low.
Piramal Pharma market capitalisation is ₹27,002.35 Cr as on .
To buy Piramal Pharma shares, you need to follow these steps:
Piramal Pharma trading volume is 21.76L as on . This means that 21.76L shares of Piramal Pharma were bought and sold on the stock market during today's trading session.